May 2013 Issue

Commentary

Hemoglobin Levels Fall, Transfusions On the Rise

Expert Q&A

New Prostate Center to Focus on Improving Everything from Diagnosis to Treatment: An Interview with Ashutosh K. Tewari, MB, BS

Subscribe
Archive

Subscribe

Editorial Board	Login \| Register

Get the App

Download our free app for iOS or Android

July 26, 2010

Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis

Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis

Sponsor and Collaborators
Chulalongkorn University

Contact
Contact: Yingyos Avihingsanon, MD
662-256-4251 ext 204

Contact: Wonngarm Kittanamongkolchai, MD

Principal Investigator
Study Director: Yingyos Avihingsanon, MD, Chulalongkorn University

ClinicalTrials.gov Identifier
NCT01042457

Next Article in Lupus Nephritis Clinical Trials

Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis

RUN Articles

MEmbranous Nephropathy Trial Of Rituximab (MENTOR)

A look at the following clinical trial: MEmbranous Nephropathy Trial Of Rituximab (MENTOR).

Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With ...

A look at the following clinical trial: Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy (RITULUP).

Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis ...

A look at the following clinical trial: Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis (RITUXILUP).